Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Aug. 31, 2019 |
Aug. 31, 2018 |
Aug. 31, 2019 |
Aug. 31, 2018 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
| Operating Expenses | ||||
| Research and development, net (Note 12) | 970,213 | 1,066,292 | 1,968,074 | 2,132,371 |
| General and administrative (Note 12) | 1,718,613 | 2,394,398 | 3,621,243 | 4,749,948 |
| Depreciation and amortization (Notes 4 and 5) | 201,403 | 110,589 | 365,739 | 211,658 |
| Interest and other finance costs | 622,183 | 13,443 | 1,124,064 | 26,481 |
| Interest income | (192,259) | (122) | (192,291) | (247) |
| Foreign exchange (gain) loss | 21,890 | (46,190) | 9,764 | (52,271) |
| Total expenses | 3,342,043 | 3,538,410 | 6,896,593 | 7,067,940 |
| Net Loss | (3,342,043) | (3,538,410) | (6,896,593) | (7,067,940) |
| Other comprehensive loss | ||||
| Foreign currency translation adjustment | 102,457 | (59,321) | (37,685) | (111,589) |
| Comprehensive Loss | $ (3,239,586) | $ (3,597,731) | $ (6,934,278) | $ (7,179,529) |
| Loss per share | ||||
| Basic and Diluted | $ (0.09) | $ (0.10) | $ (0.19) | $ (0.21) |
| Weighted average common shares outstanding | ||||
| Basic and Diluted | 38,383,156 | 33,805,706 | 36,548,832 | 33,768,516 |